Peroxynitrite causes endothelial cell monolayer barrier dysfunction

Am J Physiol Cell Physiol. 2001 Sep;281(3):C1064-75. doi: 10.1152/ajpcell.2001.281.3.C1064.

Abstract

Nitric oxide (.NO) attenuates hydrogen peroxide (H(2)O(2))-mediated barrier dysfunction in cultured porcine pulmonary artery endothelial cells (PAEC) (Gupta MP, Ober MD, Patterson C, Al-Hassani M, Natarajan V, and Hart, CM. Am J Physiol Lung Cell Mol Physiol 280: L116-L126, 2001). However,.NO rapidly combines with superoxide (O) to form the powerful oxidant peroxynitrite (ONOO(-)), which we hypothesized would cause PAEC monolayer barrier dysfunction. To test this hypothesis, we treated PAEC with ONOO(-) (500 microM) or 3-morpholinosydnonimine hydrochloride (SIN-1; 1-500 microM). SIN-1-mediated ONOO(-) formation was confirmed by monitoring the oxidation of dihydrorhodamine 123 to rhodamine. Both ONOO(-) and SIN-1 increased albumin clearance (P < 0.05) in the absence of cytotoxicity and altered the architecture of the cytoskeletal proteins actin and beta-catenin as detected by immunofluorescent confocal imaging. ONOO(-)-induced barrier dysfunction was partially reversible and was attenuated by cysteine. Both ONOO(-) and SIN-1 nitrated tyrosine residues, including those on beta-catenin and actin, and oxidized proteins in PAEC. The introduction of actin treated with ONOO(-) into PAEC monolayers via liposomes also resulted in barrier dysfunction. These results indicate that ONOO(-) directly alters endothelial cytoskeletal proteins, leading to barrier dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / metabolism
  • Animals
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cytoskeletal Proteins / metabolism
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiology*
  • Kinetics
  • Molsidomine / analogs & derivatives
  • Molsidomine / pharmacology*
  • Nitrates / pharmacology*
  • Nitric Oxide / physiology*
  • Nitric Oxide Donors / pharmacology
  • Oxidants / pharmacology
  • Pulmonary Artery
  • Reactive Oxygen Species / metabolism
  • Superoxide Dismutase / pharmacology
  • Swine
  • Trans-Activators*
  • Tyrosine / analogs & derivatives*
  • Tyrosine / metabolism
  • beta Catenin

Substances

  • Actins
  • Cytoskeletal Proteins
  • Nitrates
  • Nitric Oxide Donors
  • Oxidants
  • Reactive Oxygen Species
  • Trans-Activators
  • beta Catenin
  • peroxynitric acid
  • Nitric Oxide
  • 3-nitrotyrosine
  • Tyrosine
  • linsidomine
  • Molsidomine
  • Superoxide Dismutase